Liangqin Guo
Inventor
Stats
- 13 US patents issued
- 37 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 13 US Patents Issued
- 37 US Applications Filed
- 200 Total Citation Count
- Oct 31, 2022 Most Recent Filing
- Apr 1, 1998 Earliest Filing
Work History
Patent Owner | Applications Filed | Year |
---|---|---|
MERCK & CO., INC. | 1
1 | 2000
2005 |
Merck Sharp Dohme Corp. | 1
| 2013
|
MOCHIDA PHARMACEUTICAL CO., LTD. | 6
1 | 2013
2015 |
MERCK SHARP & DOHME CORP. | 2
2 1 7 1 2 1 1 2 6 1 1 | 1998
2001 2002 2004 2005 2006 2008 2009 2011 2013 2015 2016 |
Inventor Addresses
Address | Duration |
---|---|
Edison, NJ | Feb 15, 00 - Feb 28, 08 |
Edison, NJ, US | Feb 14, 02 - Apr 06, 21 |
Monroe Township, NJ, US | Mar 26, 20 - Apr 01, 25 |
Monroe, NJ, US | Dec 20, 18 - Dec 31, 24 |
Technology Profile
Technology | Matters | |
---|---|---|
A01N: | PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF | 1 |
A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 25 |
A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 12 |
Patents / Publication
Patents / Publication # | Year of Publication / Issued | Title | Citations |
---|---|---|---|
12264134 | 2025 | Substituted piperazine amide compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors | 0 |
12246008 | 2025 | 4-amino or 4-alkoxy-substituted aryl sulfonamide compounds with selective activity in voltage-gated sodium channels | 0 |
12178842 | 2024 | PCSK9 antagonist compounds | 0 |
12152019 | 2024 | Arylalkyl pyrazole compounds as indoleamine 2,3-dioxygenase inhibitors | 0 |
12091405 | 2024 | Substituted pyrazole compounds as indoleamine 2,3-dioxygenase inhibitors | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.